Dare Bioscience (DARE) Share-based Compensation Growth (5y) (2018 - 2025)
Dare Bioscience (DARE) Share-based Compensation Growth (5y) (2018 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Dare Bioscience | 12.36 Mn | -256,055.23 | -132,343.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 22.31% |
| Sep 30, 2025 | -5.77% |
| Dec 31, 2024 | 15.41% |
| Sep 30, 2024 | 31.06% |
| Jun 30, 2024 | 106.25% |
| Mar 31, 2024 | 11.54% |
| Dec 31, 2023 | 78.58% |
| Sep 30, 2023 | -197.75% |
| Jun 30, 2023 | 166.84% |
| Dec 31, 2022 | -15.36% |
| Sep 30, 2022 | 140.28% |
| Jun 30, 2022 | 1,023.71% |
| Mar 31, 2022 | 1,021.57% |
| Dec 31, 2021 | 169.93% |
| Jun 30, 2021 | 101.31% |
| Mar 31, 2021 | -16.07% |
| Dec 31, 2020 | -23.24% |
| Sep 30, 2020 | 110.91% |
| Dec 31, 2019 | -1.44% |
| Jun 30, 2019 | -31.05% |